These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 26277100)

  • 21. (18)F-fluorodeoxyglucose positron emission tomography versus computed tomography in predicting histopathological response to epidermal growth factor receptor-tyrosine kinase inhibitor treatment in resectable non-small cell lung cancer.
    van Gool MH; Aukema TS; Schaake EE; Rijna H; Codrington HE; Valdés Olmos RA; Teertstra HJ; van Pel R; Burgers SA; van Tinteren H; Klomp HM
    Ann Surg Oncol; 2014 Sep; 21(9):2831-7. PubMed ID: 24845729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Baseline SUVmax at PET-CT in stage IIIA non-small-cell lung cancer patients undergoing surgery after neoadjuvant therapy: prognostic implication focused on histopathologic subtypes.
    Lee HY; Lee KS; Park J; Han J; Kim BT; Kwon OJ; Ahn YC; Ahn MJ; Park K; Kim J; Shim YM
    Acad Radiol; 2012 Apr; 19(4):440-5. PubMed ID: 22265854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PET-CT-based auto-contouring in non-small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved nodal volumes.
    van Baardwijk A; Bosmans G; Boersma L; Buijsen J; Wanders S; Hochstenbag M; van Suylen RJ; Dekker A; Dehing-Oberije C; Houben R; Bentzen SM; van Kroonenburgh M; Lambin P; De Ruysscher D
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):771-8. PubMed ID: 17398018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Objective and subjective comparison of standard 2-D and fully 3-D reconstructed data on a PET/CT system.
    Strobel K; Rüdy M; Treyer V; Veit-Haibach P; Burger C; Hany TF
    Nucl Med Commun; 2007 Jul; 28(7):555-9. PubMed ID: 17538397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional nodal staging with 18F-FDG PET-CT in non-small cell lung cancer: Additional diagnostic value of CT attenuation and dual-time-point imaging.
    Li M; Wu N; Liu Y; Zheng R; Liang Y; Zhang W; Zhao P
    Eur J Radiol; 2012 Aug; 81(8):1886-90. PubMed ID: 21511421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inter-observer variations in FDG-PET interpretation for cancer screening.
    Suzuki A; Nakamoto Y; Terauchi T; Kawamoto M; Okumura Y; Suzuki Y; Sato T; Takahashi N; Lee J; Senda M; Uno K; Inoue T
    Jpn J Clin Oncol; 2007 Aug; 37(8):615-22. PubMed ID: 17704533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Training improves the interobserver agreement of the expert positron emission tomography review panel in primary mediastinal B-cell lymphoma: interim analysis in the ongoing International Extranodal Lymphoma Study Group-37 study.
    Ceriani L; Barrington S; Biggi A; Malkowski B; Metser U; Versari A; Martelli M; Davies A; Johnson PW; Zucca E; Chauvie S
    Hematol Oncol; 2017 Dec; 35(4):548-553. PubMed ID: 27545416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer.
    Cerfolio RJ; Ojha B; Bryant AS; Raghuveer V; Mountz JM; Bartolucci AA
    Ann Thorac Surg; 2004 Sep; 78(3):1017-23; discussion 1017-23. PubMed ID: 15337041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Additional value of FDG-PET to contrast enhanced-computed tomography (CT) for the diagnosis of mediastinal lymph node metastasis in non-small cell lung cancer: a Japanese multicenter clinical study.
    Kubota K; Murakami K; Inoue T; Itoh H; Saga T; Shiomi S; Hatazawa J
    Ann Nucl Med; 2011 Dec; 25(10):777-86. PubMed ID: 21901365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives.
    Nestle U; Kremp S; Grosu AL
    Radiother Oncol; 2006 Nov; 81(2):209-25. PubMed ID: 17064802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Platinum-Based Chemoradiotherapy on Cellular Proliferation in Bone Marrow and Spleen, Estimated by (18)F-FLT PET/CT in Patients with Locally Advanced Non-Small Cell Lung Cancer.
    Leimgruber A; Möller A; Everitt SJ; Chabrot M; Ball DL; Solomon B; MacManus M; Hicks RJ
    J Nucl Med; 2014 Jul; 55(7):1075-80. PubMed ID: 24868108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computer-aided detection (CAD) and assessment of malignant lesions in the liver and lung using a novel PET/CT software tool: initial results.
    Hahn S; Heusner T; Zhou X; Zhan Y; Peng Z; Hamami M; Forsting M; Bockisch A; Antoch G
    Rofo; 2010 Mar; 182(3):243-7. PubMed ID: 19859858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measurement of inter- and intra-observer variability in the routine clinical interpretation of brain 18-FDG PET-CT.
    Brucher N; Mandegaran R; Filleron T; Wagner T
    Ann Nucl Med; 2015 Apr; 29(3):233-9. PubMed ID: 25416147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inter-observer agreement improves with PERCIST 1.0 as opposed to qualitative evaluation in non-small cell lung cancer patients evaluated with F-18-FDG PET/CT early in the course of chemo-radiotherapy.
    Fledelius J; Khalil A; Hjorthaug K; Frøkiær J
    EJNMMI Res; 2016 Dec; 6(1):71. PubMed ID: 27655428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Locating hyperfunctioning parathyroid glands using
    Christensen JW; Jensen LT; Søndergaard SB; Broholm R; Haarmark C; Krakauer M; Bennedbæk FN; Zerahn B; Trolle W; Hahn CH; Kristensen B
    Eur J Hybrid Imaging; 2021 Jul; 5(1):13. PubMed ID: 34227025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inter-observer agreement for Crohn's disease sub-phenotypes using the Montreal Classification: How good are we? A multi-centre Australasian study.
    Krishnaprasad K; Andrews JM; Lawrance IC; Florin T; Gearry RB; Leong RW; Mahy G; Bampton P; Prosser R; Leach P; Chitti L; Cock C; Grafton R; Croft AR; Cooke S; Doecke JD; Radford-Smith GL
    J Crohns Colitis; 2012 Apr; 6(3):287-93. PubMed ID: 22405164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bowel wall thickening on computed tomography scan: Inter-observer agreement and correlation with endoscopic findings.
    Daniel F; Alsheikh M; Ghieh D; Hosni M; Tayara Z; Tamim H; Abi-Ghanem AS; El-Merhi F
    Arab J Gastroenterol; 2020 Dec; 21(4):219-223. PubMed ID: 32653241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blinded and uniform cause of death verification in a lung cancer CT screening trial.
    Horeweg N; van Klaveren RJ; Groen HJ; Lammers JW; Weenink C; Nackaerts K; Mali W; Oudkerk M; de Koning HJ
    Lung Cancer; 2012 Sep; 77(3):522-5. PubMed ID: 22627027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using PET for therapy monitoring in oncological clinical trials: challenges ahead.
    Deroose CM; Stroobants S; Liu Y; Shankar LK; Bourguet P
    Eur J Nucl Med Mol Imaging; 2017 Aug; 44(Suppl 1):32-40. PubMed ID: 28451825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inter-observer agreement and reliability assessment for observational studies of clinical work.
    Walter SR; Dunsmuir WTM; Westbrook JI
    J Biomed Inform; 2019 Dec; 100():103317. PubMed ID: 31654801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.